These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9741405)

  • 1. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.
    Hirohata S; Suda H; Hashimoto T
    J Neurol Sci; 1998 Aug; 159(2):181-5. PubMed ID: 9741405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease].
    Suda H
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):13-22. PubMed ID: 11185687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years.
    Kikuchi H; Aramaki K; Hirohata S
    Adv Exp Med Biol; 2003; 528():575-8. PubMed ID: 12918768
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of infliximab in progressive neuro-Behçet's syndrome.
    Kikuchi H; Aramaki K; Hirohata S
    J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic Progressive Neuro-Behçet's Disease].
    Hirohata S
    Brain Nerve; 2021 May; 73(5):568-575. PubMed ID: 34006690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
    Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
    Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease.
    Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
    J Neurol Sci; 2015 Feb; 349(1-2):143-8. PubMed ID: 25601769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central nervous system involvement in rheumatic diseases].
    Hirohata S
    Nihon Rinsho; 1999 Feb; 57(2):409-12. PubMed ID: 10078015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central nervous system involvement in Behçet's disease].
    Hirohata S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1147-9. PubMed ID: 12235822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.
    Hirohata S; Kikuchi H
    Intern Med; 2012; 51(24):3359-65. PubMed ID: 23257520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent aspects of Neuro-Behcet's disease].
    Hirohata S
    Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.
    Bae JH; Lee SC
    Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurological manifestations of Behcet's disease: 22 cases among 170 patients].
    Tohmé A; Koussa S; Haddad-Zébouni S; El-Rassi B; Ghayad E
    Presse Med; 2009 May; 38(5):701-9. PubMed ID: 19062244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory neuro-Behçet treated by tocilizumab: a case report.
    Urbaniak P; Hasler P; Kretzschmar S
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S73-5. PubMed ID: 23020826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of the central nervous system in Behçet's syndrome. Report of two cases (author's transl)].
    Bergevin H; Bakouche P; Chaouat D; Nicolle MH; Reignier A; Nick J
    Sem Hop; 1980 Mar 18-25; 56(11-12):533-8. PubMed ID: 6245453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central nervous system involvement in connective tissue diseases].
    Hirohata S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):109-17. PubMed ID: 15291247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
    Pitman SW; Frei E
    Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
    Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
    Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease.
    Kikuchi H; Takayama M; Hirohata S
    J Neurol Sci; 2014 Feb; 337(1-2):80-5. PubMed ID: 24289890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.